Increased Expression of Adam33 and Adam8 with Disease Progression in Asthma.
From: Meakins-Christie Laboratories, McGill University, Montreal Chest Institute, Montréal, Québec, Canada.
The Journal of allergy and clinical immunology
- Publish Date: Apr 2007
- ISSN: 0091-6749
- Volume: 119
- Issue: 4
- Pages: 863-71
- Medium: Print
- Language: English
- Citation (JAMA): Foley Susan C, Mogas Andrea K, Olivenstein Ron, et al. Increased Expression of Adam33 and Adam8 with Disease Progression in Asthma.. J. Allergy Clin. Immunol. Apr 2007;119:863-71
Abstract
BACKGROUND: ADAM33, a disintegrin and metalloproteinase 33 gene, has been identified as a risk factor for asthma and bronchial hyperresponsiveness and has been postulated as a gene for airway remodeling. ADAM8 is strongly induced by allergens and T(H)2 cytokines in the lung in experimental asthma. OBJECTIVES: To assess the importance of these genes in asthma pathogenesis and to investigate whether expression relates to disease severity or deterioration in lung function, we measured the mRNA and protein expression of both genes in bronchial biopsies of subjects with asthma and control subjects. METHODS: RNA was extracted from frozen endobronchial biopsies of mild, moderate, and severe adults with asthma and controls. Subjects with moderate and severe asthma were taking corticosteroids. The mRNA transcript of both genes was measured by real time RT-PCR using specific primers. Protein expression was examined by immunohistochemistry on paraffin sections. RESULTS: ADAM33 mRNA expression was significantly higher in both moderate and severe asthma compared with mild asthma (P < .05) and controls. Immunostaining for ADAM33 was increased in the epithelium, submucosal cells, and smooth muscle in severe asthma compared with mild disease and controls. ADAM8 mRNA expression was significantly increased in all asthma groups compared with controls. Increased inflammatory cells stained positive for ADAM8 in both moderate (P < .05) and severe asthma (P < .005) compared with mild disease. CONCLUSIONS: These results demonstrate increased expression of both ADAM genes as asthma severity increases. CLINICAL IMPLICATIONS: These genes may contribute to the remodeling process that occurs with asthma progression and may have implications for future treatment in severe disease.
Mesh Headings (Keywords): ADAM Proteins, Adult, Asthma, Cells, Cultured, Disease Progression, Female, Humans, Male, Membrane Proteins, Middle Aged
Check for Full Text / PubMed Unique Identifier (PMID): 17339047
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.